Bart Molemans

EU-Wi<i>d</i>e Cross-Section<i>a</i>l Obser<i>v</i>at<i>i</i>o<i>n</i>al Study of Lipid-Modifying Therapy Use in Se<i>c</i>ondary and Pr<i>i</i>mary Care: the DA VINCI study

Kausik K. Ray, Bart Molemans, W. Marieke Schoonen et al. · European Journal of Preventive Cardiology · 2020 · 767 citations · Full text

Medicine, Cardiology, Pharmacotherapy +16

The OPTIMA Study

Piergiorgio Messa, Magdi Yaqoob, Koen Bouman et al. · Clinical Journal of the American Society of Nephrology · 2008 · 221 citations · Full text

Medicine, Nephrology, Pharmacotherapy +17

Hemoglobin Variability Does Not Predict Mortality in European Hemodialysis Patients

Kai‐Uwe Eckardt, Joseph Kim, Florian Kronenberg et al. · Journal of the American Society of Nephrology · 2010 · 67 citations · Full text

Medicine, Hematology, Nephrology +15

Serum phosphate optimal timing and range associated with patients survival in haemodialysis: the COSMOS study

José Luis Fernández Martín, Adriana Dusso, Pablo Martínez‐Camblor et al. · Nephrology Dialysis Transplantation · 2018 · 32 citations

Medicine, Endocrinology, Nephrology +17

An Epidemiological Study of Hemodialysis Patients Based on the European Fresenius Medical Care Hemodialysis Network: Results of the ARO Study

Ángel L.M. de Francisco, Joseph Kim, Stefan D. Anker et al. · Nephron Clinical Practice · 2010 · 26 citations · Full text

Medicine, Nephrology, Dialysis +16